ATE471711T1 - Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen - Google Patents

Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen

Info

Publication number
ATE471711T1
ATE471711T1 AT07788135T AT07788135T ATE471711T1 AT E471711 T1 ATE471711 T1 AT E471711T1 AT 07788135 T AT07788135 T AT 07788135T AT 07788135 T AT07788135 T AT 07788135T AT E471711 T1 ATE471711 T1 AT E471711T1
Authority
AT
Austria
Prior art keywords
release
subcutaneous implants
active substance
longer period
substance over
Prior art date
Application number
AT07788135T
Other languages
English (en)
Inventor
Patrice Mauriac
Pierre Marion
Original Assignee
Mediolanum Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Pharmaceuticals Ltd filed Critical Mediolanum Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE471711T1 publication Critical patent/ATE471711T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07788135T 2006-08-02 2007-08-01 Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen ATE471711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001538A ITMI20061538A1 (it) 2006-08-02 2006-08-02 Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
PCT/EP2007/057967 WO2008015236A1 (en) 2006-08-02 2007-08-01 Subcutaneous implants releasing an active principle over an extended period of time

Publications (1)

Publication Number Publication Date
ATE471711T1 true ATE471711T1 (de) 2010-07-15

Family

ID=37776598

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07788135T ATE471711T1 (de) 2006-08-02 2007-08-01 Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen

Country Status (17)

Country Link
US (1) US20100062037A1 (de)
EP (1) EP2054029B9 (de)
JP (1) JP2009545563A (de)
KR (1) KR20090048463A (de)
CN (1) CN101522170B (de)
AT (1) ATE471711T1 (de)
AU (1) AU2007280395A1 (de)
BR (1) BRPI0714820A2 (de)
CA (1) CA2659440A1 (de)
DE (1) DE602007007338D1 (de)
EA (1) EA015795B1 (de)
ES (1) ES2347716T3 (de)
IT (1) ITMI20061538A1 (de)
MX (1) MX2009001230A (de)
PL (1) PL2054029T3 (de)
PT (1) PT2054029E (de)
WO (1) WO2008015236A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2817249T3 (es) 2007-04-16 2021-04-06 Corium Inc Matrices de microagujas obtenidas mediante disolución y colada que contienen un principio activo
CN104288844A (zh) * 2007-10-18 2015-01-21 杜雷科特公司 具有可控堆积密度的可生物降解植入物
EP2566501B1 (de) 2010-05-04 2019-03-13 Corium International, Inc. Verfahren und vorrichtung zur transdermalen verabreichung von parathormon mithilfe eines mikroprojektions-arrays
EP2739287B1 (de) * 2011-08-04 2017-07-05 Flexion Therapeutics, Inc. Corticosteroide zur behandlung von gelenkschmerzen
EP2934660B1 (de) 2012-12-21 2019-07-17 Corium, Inc. Mikroarray zur freisetzung therapeutischer wirkstoffe und verfahren zur herstellung davon
EP4094799A1 (de) 2013-03-12 2022-11-30 Corium, Inc. Mikroprojektionsapplikatoren
US10384046B2 (en) * 2013-03-15 2019-08-20 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
WO2014150285A2 (en) 2013-03-15 2014-09-25 Corium International, Inc. Multiple impact microprojection applicators and methods of use
US10384045B2 (en) 2013-03-15 2019-08-20 Corium, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
CN103446041B (zh) * 2013-08-27 2015-06-10 青岛东辉医药科技发展有限公司 一种亮丙瑞林缓控释药棒及其制备方法
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
US10857093B2 (en) 2015-06-29 2020-12-08 Corium, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
RU2612826C1 (ru) * 2015-12-30 2017-03-13 Артур Магомедович Омаров Блок имплантата для реконструкции дефектной части альвеолярного отростка и способ реконструкции дефектной части альвеолярного отростка
DE102018127200B3 (de) * 2018-10-31 2019-07-25 Andreas Haas Implantat zum subkutanen implantieren
GB202106973D0 (en) * 2021-05-14 2021-06-30 Locate Bio Ltd Osteoconductive implant material with BMP-2 delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
JPH08157370A (ja) * 1994-12-06 1996-06-18 Banyu Pharmaceut Co Ltd フィナステリド含有徐放性組成物
US20030211157A1 (en) * 1996-05-06 2003-11-13 Simon David Lew Semi-sol delivery blend for water soluble molecules
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
IL133105A (en) * 1997-06-04 2004-09-27 Debio Rech Pharma Sa Implants for controlled release of pharmaceutically active principles and method for making same
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
CA2530120A1 (en) * 2003-06-26 2005-01-06 Mediolanum Pharmaceuticals Ltd. Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies

Also Published As

Publication number Publication date
ES2347716T3 (es) 2010-11-03
PT2054029E (pt) 2010-10-04
HK1131547A1 (en) 2010-01-29
CA2659440A1 (en) 2008-02-07
US20100062037A1 (en) 2010-03-11
EP2054029B1 (de) 2010-06-23
PL2054029T3 (pl) 2010-11-30
EA015795B1 (ru) 2011-12-30
EP2054029A1 (de) 2009-05-06
JP2009545563A (ja) 2009-12-24
WO2008015236A1 (en) 2008-02-07
DE602007007338D1 (de) 2010-08-05
CN101522170A (zh) 2009-09-02
CN101522170B (zh) 2013-04-24
EP2054029B9 (de) 2011-02-02
MX2009001230A (es) 2009-04-28
EA200900246A1 (ru) 2009-06-30
KR20090048463A (ko) 2009-05-13
WO2008015236A8 (en) 2008-06-05
ITMI20061538A1 (it) 2008-02-03
AU2007280395A1 (en) 2008-02-07
BRPI0714820A2 (pt) 2013-05-21

Similar Documents

Publication Publication Date Title
ATE471711T1 (de) Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen
WO2008098019A3 (en) Polymer formulations for delivery of bioactive agents
WO2010005723A3 (en) Drug loaded polymeric nanoparticles and methods of making and using same
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
MX2018005413A (es) Materiales de poliuretano/urea.
DE602004015848D1 (de) Bioabbaubare zusammensetzungen enthaltend polylactid-polymere, adipat copolymere und magnesiumsilikat
ATE382337T1 (de) Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
JP2011508791A5 (de)
AU2003267581A8 (en) Drug delivery
WO2013036309A3 (en) Sustained release formulations for delivery of proteins to the eye and methods of preparing same
WO2007130134A3 (en) Controlled release microparticles
AR082225A1 (es) Material compuesto polimerico con funcionalidad biocida
WO2007011955A3 (en) Drug-containing implants and methods of use thereof
TW200630128A (en) Active ingredient-containing silicone elastomers
AR093059A1 (es) Mezclas de polimeros bioabsorbibles
MX2009001231A (es) Implantes subcutaneos que liberan un principio activo durante un periodo de tiempo extendido.
WO2012172433A3 (en) A sustained -release composition containing a melanocortin receptor ligand as the active ingredient
DE602006016127D1 (de) Zusammensetzung und dosierform mit einer festen oder halbfesten matrix
ATE438385T1 (de) Pharmazeutische zusammensetzung
TW200624464A (en) Amphiphilic block copolymer and pharmaceutical formulation comprising the same
MX2007007099A (es) Implante formado in situ para animales.
MX2021002459A (es) Formas de dosificacion en capsula disuasorias del abuso de liberacion inmediata.
UA92604C2 (ru) Композиция стансопорфина с физиологической осмотической концентрацией и ее применение
ATE451913T1 (de) Subkutane implantate, die über einen längeren zeitraum einen wirkstoff freisetzen
MX2007001721A (es) Composiciones de alimento para mascotas que tienen una propiedad de relajacion definida.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2054029

Country of ref document: EP